logo
These Diseases Are on the Rise as Vaccine Rates Decrease

These Diseases Are on the Rise as Vaccine Rates Decrease

Newsweeka day ago
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
The U.S. vaccination rate is on a steady multiyear decline, with the Centers of Disease Prevention and Control reporting that coverage for all children entering kindergarten in the 2024-25 school year declined for all reported vaccines.
The measles, mumps, rubella (MMR) vaccine has dropped to 92.5 percent, down from 92.7 percent last year. The overall vaccine exemption rate also climbed to 3.6 percent.
Experts are now warning that the declines in vaccine coverage in the United States has led to notable increases in several diseases, including measles, whooping cough and hand, foot and mouth disease.
Why It Matters
Health authorities, researchers, and global health leaders have warned that continued decreases in childhood vaccinations could reverse decades of progress in controlling these illnesses, resulting in higher rates of infection, hospitalizations, and preventable deaths.
According to the CDC, small declines in coverage have already contributed to localized outbreaks, while modeling studies predict far greater spread if the trend continues.
One year-old River Jacobs is held by his mother, Caitlin Fuller, while he receives an MMR vaccine from Raynard Covarrubio, at a vaccine clinic put on by Lubbock Public Health Department on March 1, 2025,...
One year-old River Jacobs is held by his mother, Caitlin Fuller, while he receives an MMR vaccine from Raynard Covarrubio, at a vaccine clinic put on by Lubbock Public Health Department on March 1, 2025, in Lubbock, Texas. MoreWhat To Know
The falling immunization rates are already making an impact on U.S. public health, doctors say.
In Philadelphia, an uptick in hand, foot, and mouth disease cases closed a local pool and sent numerous children to urgent care.
"Each of our centers across the Philadelphia and surrounding county area are seeing multiple cases," Dr. Bob Czincila, medical director of Vybe urgent care, told CBS News, noting that transmission is especially prevalent in day care settings and summer camps.
Hand, foot and mouth disease is a viral infection that can be painful, often making it difficult for young children to eat and drink and increasing the risk of dehydration. There is no specific treatment other than symptom relief.
South Carolina's Department of Public Health also recently reported a 124 percent increase in whooping cough cases over the past year, with 551 cases confirmed, many among children in child care centers and schools.
Health officials advised antibiotics as the primary treatment and emphasized that vaccination remains the best means of prevention.
Meanwhile, measles, long declared eliminated in the United States, has seen a resurgence is cases.
Texas experienced over 750 cases since January, resulting in at least two deaths.
These outbreaks have primarily originated in communities with low vaccination rates. JAMA modeling studies and CDC data show regional drops in childhood immunizations; for example, kindergarten coverage for measles, polio, whooping cough, and chickenpox fell from 95 percent before the pandemic to below 93 percent afterward, with some states experiencing much larger declines.
Epidemiologists warn that drops in vaccination not only increase individual infection risk, but also threaten herd immunity, leaving newborns, immunocompromised individuals, and the elderly particularly vulnerable.
"It is not so common in patients over the age of 20, but there are increasing outbreaks. I attribute this to declining vaccination coverage due to misinformation, increased global travel and less healthy lifestyles overall including poor diet," board-certified internist Dr. Amanda Kahn told Newsweek.
CDC experts note that disparities in vaccination persist, with lower coverage reported among children from racial and ethnic minorities, economically disadvantaged households, and rural areas.
What People Are Saying
Board-certified internist Dr. Amanda Kahn told Newsweek: "I am now checking all adult patients for measles immunity given that measles cases are on the rise. Measles is something we typically see in unvaccinated children or infants who are too young to be vaccinated, however I do see waning immunity in adults who were previously vaccinated, and now recommend a booster."
Dr. Bob Czincila, medical director of Vybe urgent care, told CBS Philadelphia, regarding the spread of hand, foot, and mouth disease: "Kids are coming in with rashes that are on their fingers, on their hands, they can be on their toes and feet, and then you have oral ulcerations. It makes it difficult for children, especially younger ones, to eat because of how painful and how much they burn... It's primarily in children, but certainly, we have adults that have younger children that may contract it from them, that come in as well too."
Mathew Kiang, ScD, assistant professor of epidemiology and population health at Stanford Medicine, said in an earlier report: "If vaccination were to fall by even 10 percent today, measles cases would skyrocket to 11.1 million over the next 25 years. If vaccination rates were cut in half, we'd expect 51.2 million cases of measles, 9.9 million cases of rubella, 4.3 million cases of polio and 200 cases of diphtheria over 25 years."
What Happens Next
Public health experts have emphasized that maintaining or increasing vaccination rates is critical for preventing further disease resurgence.
Modeling studies indicate that even a small increase, around 5 percent, in vaccine coverage could dramatically reduce future outbreaks and bring disease levels back toward elimination thresholds. Meanwhile, continued decline could permanently reestablish diseases such as measles, rubella, and polio in the U.S.
The CDC and health providers recommend that parents consult with pediatricians to ensure all children are up-to-date on vaccinations.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump Brushes Off Major Success From First Term: 'Long Time Ago'
Trump Brushes Off Major Success From First Term: 'Long Time Ago'

Newsweek

time43 minutes ago

  • Newsweek

Trump Brushes Off Major Success From First Term: 'Long Time Ago'

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. President Donald Trump on Wednesday brushed off what is widely considered to be among the biggest uncontested successes of his first term while reacting to Health and Human Services Secretary Robert F. Kennedy Jr.'s move to pull $500 million in funding for next-generation mRNA-based vaccines to tackle viruses like Covid, H5N1 and the flu. "You were the driving force behind Operation Warp Speed, these mRNA vaccines that are the gold standard," a reporter asked Trump during a White House event on Wednesday. Operation Warp Speed was a 2020 public-private partnership, initiated by the first Trump administration, aimed at accelerating the development and distribution of a COVID-19 vaccine. At the time, it was almost universally accepted that an effective vaccine for the coronavirus was at least 18 months to two years away. Trump's operation did it in less than a year. "Now, your health secretary is pulling back all the funding for research, he's saying that the risks outweigh the benefits, which puts him at odds with the entire medical community, and with you," the reporter continued. "What's going on?" "Research on what?" Trump asked. "Into mRNA vaccines," she clarified. "Well, we're going to look at that," the president replied. "We're talking about it and they're doing a very good job, and you know, that is a pass." Trump went on to briefly acknowledge the success of Operation Warp Speed before dismissing it. "Operation Warp Speed was, whether you're a Republican or Democrat, considered one of the most incredible things ever done in this country," the president said. "The efficiency, the way it was done, the distribution, everything about it has been amazing." Then he added: "But, you know, that was now a long time ago. And we're onto other things, but we are speaking about it. We have meetings about it ... we're looking for other answers to other problems, to other sicknesses and diseases and I think we're doing really well." This is a breaking news story. Updates to follow.

French Bulldog's Reaction to Smelling Again After Surgery Delights Internet
French Bulldog's Reaction to Smelling Again After Surgery Delights Internet

Newsweek

time2 hours ago

  • Newsweek

French Bulldog's Reaction to Smelling Again After Surgery Delights Internet

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A video of a dog's reaction to smelling food for the first time after surgery melted people's hearts. A French bulldog named Kygo recently underwent surgery for a condition known as brachycephalic obstructive airway syndrome, or BOAS. The surgery helps alleviate the breathing difficulties of brachycephalic dog breeds—like English bulldogs, pugs and Boston terriers—an article from the Cornell University College of Veterinary Medicine said. The "nose job" surgery, as his owners called it on the dog's TikTok account @ involved opening his nostrils, reducing the soft palate and then removing laryngeal saccules to prevent further obstructions. And 24 hours postsurgery, Kygo's entire life changed as he rediscovered his sense of smell. In last week's TikTok video, which amassed over 7.5 million views and 1.6 million likes, Kygo intently sat next to his owners as they ate. He looked up with eyes full of amazement because the food smells wafted through his nostrils for the very first time since surgery. Screenshots from a TikTok video of a French bulldog smelling food for the first time after nose surgery. Screenshots from a TikTok video of a French bulldog smelling food for the first time after nose surgery. @ He wasn't begging for a nibble of their food, as many dogs might have done. Instead, he tilted his head higher, embracing all the delicious aromas in a new way he hadn't experienced before. His nostrils flared in and out in amazement. Now, he's a smelling machine and can't get enough whiffs of everything around him. Newsweek reached out to the owners via email for additional information and comment. What Do the Comments Say? With over 5,770 comments, the TikTok video started a debate among viewers. Many fell in love with Kygo's precious reaction, calling him the "goodest sniffer." "Sniffing in HD now," wrote a viewer, while another pointed out: "The way he looked at you after the first sniff was like, 'Omg, you right!'" A third user commented: "He looks like he's suspicious about his newfound sense of smell." However, others believed this clip shined a light on the dangers of breeding dogs. They claimed the surgery could have been avoided. "The fact we have to perform this surgery on some breeds in the first place is HIGHLY upsetting," a person said. The article from Cornell said BOAS is a genetic condition, and these dogs, which have difficulty breathing, require surgical therapy or have a hypoplastic trachea, should not be considered for breeding. Do you have funny and adorable videos or pictures of your pet you want to share? Send them to life@ with some details about your best friend, and they could appear in our Pet of the Week lineup.

Alzheimer's: Scientists Discover What Sparks Disease
Alzheimer's: Scientists Discover What Sparks Disease

Newsweek

time7 hours ago

  • Newsweek

Alzheimer's: Scientists Discover What Sparks Disease

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Lithium deficiency in the brain could be a cause of Alzheimer's disease—and a new potential target for treatment. Ten years in the making, this is the finding of researchers at Harvard Medical School who have revealed how lithium plays an essential role in brain function and may provide resistance against brain aging and Alzheimer's. Lithium is a chemical element, currently used as medicine to treat mood disorders like mania and bipolar disorder. "Most people associate lithium with psychiatric treatment. Our study shows, for the first time, that naturally occurring lithium plays a crucial role in maintaining brain health during aging—even at concentrations far below those used in clinical psychiatry," study authors Bruce Yankner and Liviu Aron told Newsweek. The findings are based on a series of experiments in mice and on analyses of human brain tissue and blood samples from individuals in various stages of cognitive health. Lithium carbonate tablet bottles on shelf. Lithium carbonate tablet bottles on shelf. Getty Images "We found that lithium is uniquely depleted in the brains of people with mild cognitive impairment—a precursor to Alzheimer's. This makes lithium deficiency one of the earliest biochemical signs of the disease, possibly years before clinical symptoms appear," the duo explained. "We also saw that higher endogenous lithium levels were associated with preserved cognitive function even in individuals without Alzheimer's. So, this isn't just about preventing disease—it's about supporting healthy brain aging in general. The new revelation helps to explain why some people with Alzheimer's-like abnormalities in the brain don't go on to develop the disease. While genetic and environmental factors play a role, scientists also haven't been able to suggest why some people with the same risk factors might develop it and others don't—until now. The scientists unearthed that lithium loss in the human brain is one of the earliest changes leading to Alzheimer's. In mice, meanwhile, similar lithium depletion accelerated brain pathology (disease or abnormality) and memory decline. They also found reduced lithium levels stemmed from binding to amyloid plaques (misfolded proteins found between nerve cells found in the brains of people with Alzheimer's) and impaired uptake in the brain. One pair of boxes shows fewer green amyloid clusters on the left and more on the right. Another pair of boxes shows a dim arc of purple and red tau on the left and a... One pair of boxes shows fewer green amyloid clusters on the left and more on the right. Another pair of boxes shows a dim arc of purple and red tau on the left and a brighter arc on the right. More Yankner Lab In their final set of experiments, they found a new lithium compound that avoids "capture" by amyloid plaques restored memory in mice. "In people that start experiencing memory loss, the so-called mild cognitive impairment, lithium gets trapped by amyloid plaques—reducing its availability just when it's most needed to protect against inflammation and neurodegeneration," Yankner and Aron explained. "This creates a self-perpetuating feedback loop of worsening pathology and accelerating disease progression and memory loss." This all ties together decades-long observations in patients and provides a new theory of the disease and strategy for early diagnosis, prevention and treatment, according to the researchers. Recently developed treatments that target amyloid beta (a key component of the amyloid plaques) typically don't reverse memory loss and only modestly reduce the rate of decline. "The idea that lithium deficiency could be a cause of Alzheimer's disease is new and suggests a different therapeutic approach," said Yankner in a statement. Researchers had previously found lithium to be the only metal that had markedly different levels across people with and without Alzheimer's at different stages. But Yankner added in a statement, "Lithium turns out to be like other nutrients we get from the environment, such as iron and vitamin C. "It's the first time anyone's shown that lithium exists at a natural level that's biologically meaningful without giving it as a drug." Previous population studies have shown that higher lithium levels in the environment, including in drinking water, tracked with lower rates of dementia. Woman hugging her elderly mother. Woman hugging her elderly mother. PIKSEL/Getty Images Yankner's team demonstrated in mice that lithium depletion isn't just linked to Alzheimer's, it actually helps drive it. This raises hope that one day lithium could be used to treat the disease in its entirety rather than focusing on a single factor like amyloid beta or tau (another Alzheimer's-associated protein), Yankner said. Crucially, the researchers discovered that as amyloid beta begins to form deposits in the early stages of dementia in both humans and mouse models, it binds to lithium, reducing lithium's function in the brain. The reduced levels of lithium affect all major brain cell types and, in mice, lead to changes similar to those seen in Alzheimer's disease, including memory loss. Treating mice with the most potent amyloid-evading compound, called lithium orotate, reversed Alzheimer's pathology, prevented brain cell damage and restored memory. While the findings need to be confirmed in humans through clinical trials, they suggest that measuring lithium levels could help screen for early Alzheimer's. They also highlight the importance of testing amyloid-evading lithium compounds for treatment or prevention. While other lithium compounds are already used to treat bipolar disorder and clinical depression, they are given at much higher concentrations that can be toxic to some people, the researchers flag. Yankner's team discovered lithium orotate is effective at one-thousandth that dose— enough to mimic the natural level of lithium in the brain. Mice treated for nearly their entire adult lives showed no evidence of toxicity, the study found. If further studies confirm these findings, the researchers say lithium screening through routine blood tests may one day offer a way to identify individuals at risk for Alzheimer's who would benefit from treatment to prevent or delay disease onset. "Our study adds to growing evidence that Alzheimer's may be preventable—with something as simple as keeping brain lithium at healthy levels as we age," said Yankner and Aron. "Clinical trials [on humans] could test the impact of low-dose supplementation on cognitive health and dementia risk." Before lithium is proved to be safe and effective in protecting against neurodegeneration in humans, Yankner emphasized that people should not take lithium compounds on their own. Do you have a health story to share with Newsweek? Do you have a question about Alzheimer's? Let us know via health@ Reference Aron, L., Ngian, Z. K., Qiu, C., Choi, J., Liang, M., Drake, D. M., Hamplova, S. E., Lacey, E. K., Roche, P., Yuan, M., Hazaveh, S. S., Lee, E. A., Bennett, D. A., & Yankner, B. A. (2025). Lithium deficiency and the onset of Alzheimer's disease. Nature.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store